Sign In
Buy SGEN
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles
10:40am, Thursday, 10'th Nov 2022
Biogen and Seagen tapped new CEOs on Thursday but the biotech stocks diverged following the long-anticipated announcements. The post Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles app
Final Trades: Honeywell, XPO Logistics, Seagen & more
02:18pm, Monday, 31'st Oct 2022
The "Halftime Report" traders give their top picks to watch for the second half.
Seagen's (SGEN) Q3 Earnings Miss, Revenues Surpass Estimates
01:18pm, Friday, 28'th Oct 2022 Zacks Investment Research
Seagen (SGEN) reports a wider-than-expected loss in the third quarter of 2022 while its revenues beat estimates. The company raises total revenue guidance for 2022.
Seagen Inc. (SGEN) Q3 2022 Earnings Call Transcript
06:30am, Friday, 28'th Oct 2022 The Motley Fool
SGEN earnings call for the period ending September 30, 2022.
Seagen Inc. (SGEN) Q3 2022 Earnings Call Transcript
09:30pm, Thursday, 27'th Oct 2022
Seagen Inc. (NASDAQ:SGEN ) Q3 2022 Earnings Conference Call October 27, 2022 4:30 PM ET Company Participants Doug Maffei - Vice President, Investor Relations Roger Dansey - Interim Chief Executive Off
Seattle Genetics (SGEN) Reports Q3 Loss, Tops Revenue Estimates
09:25pm, Thursday, 27'th Oct 2022 Zacks Investment Research
Seattle Genetics (SGEN) delivered earnings and revenue surprises of -11.96% and 8.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Seattle Genetics (SGEN) Reports Q3 Loss, Tops Revenue Estimates
06:48pm, Thursday, 27'th Oct 2022
Seattle Genetics (SGEN) delivered earnings and revenue surprises of -11.96% and 8.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q3 Earnings Expected to Decline
02:02pm, Tuesday, 25'th Oct 2022 Zacks Investment Research
Rhythm Pharmaceuticals, Inc. (RYTM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
I Called This October Rally In August, Keep Your Seat Belts On
03:17am, Monday, 24'th Oct 2022 Seeking Alpha
After a barely discernible bottoming process, the rally has become obvious. Read more to see how I intend to take advantage of this rally.
What 8 Analyst Ratings Have To Say About Seagen
08:16pm, Thursday, 13'th Oct 2022 Benzinga
Within the last quarter, Seagen (NASDAQ:SGEN) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
6
0
0
0
Last 30D
0
1
Morgan Stanley Maintains Overweight Rating for Seagen: Here's What You Need To Know
04:10pm, Thursday, 13'th Oct 2022 Benzinga
Morgan Stanley has decided to maintain its Overweight rating of Seagen (NASDAQ:SGEN) and lower its price target from $181.00 to $170.00.
Shares of Seagen are trading up 0.36% over the last 24 hours, a
Is Seagen Stock a Buy Now?
12:21pm, Wednesday, 12'th Oct 2022 The Motley Fool
It's growing faster than competitors, but headwinds might soon bog it down.
Is Seagen Stock a Buy Now?
08:21am, Wednesday, 12'th Oct 2022
It's growing faster than competitors, but headwinds might soon bog it down.
With Meaningful Upside, This Cancer Stock Earns Analyst Upgrade
06:38pm, Tuesday, 11'th Oct 2022 Benzinga
BMO Capital Markets upgraded Seagen Inc (NASDAQ: SGEN) from Market Perform to Outperform with a price target of $178 from $177, saying the core business is undervalued.
BMO forecasts SGEN's commer
BMO Capital Upgrades Seagen: Here's What You Need To Know
04:02pm, Tuesday, 11'th Oct 2022 Benzinga
BMO Capital upgraded its rating of Seagen (NASDAQ:SGEN) to Outperform with a price target of $178.00, changing its price target from $177.00 to $178.00.
Shares of Seagen are trading up 2.5% over the l
